X-101275266-C-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001168474.2(TAF7L):c.1042G>C(p.Val348Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000137 in 1,164,382 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001168474.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAF7L | ENST00000356784.2 | c.1042G>C | p.Val348Leu | missense_variant | Exon 12 of 13 | 1 | NM_001168474.2 | ENSP00000349235.1 | ||
TAF7L | ENST00000372907.7 | c.1300G>C | p.Val434Leu | missense_variant | Exon 12 of 13 | 1 | ENSP00000361998.3 | |||
TAF7L | ENST00000324762.10 | c.820G>C | p.Val274Leu | missense_variant | Exon 10 of 11 | 2 | ENSP00000320283.6 |
Frequencies
GnomAD3 genomes AF: 0.0000278 AC: 3AN: 107850Hom.: 0 Cov.: 23 AF XY: 0.0000323 AC XY: 1AN XY: 30986
GnomAD3 exomes AF: 0.0000191 AC: 3AN: 157212Hom.: 0 AF XY: 0.0000201 AC XY: 1AN XY: 49682
GnomAD4 exome AF: 0.0000123 AC: 13AN: 1056532Hom.: 0 Cov.: 25 AF XY: 0.00000907 AC XY: 3AN XY: 330642
GnomAD4 genome AF: 0.0000278 AC: 3AN: 107850Hom.: 0 Cov.: 23 AF XY: 0.0000323 AC XY: 1AN XY: 30986
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1300G>C (p.V434L) alteration is located in exon 12 (coding exon 12) of the TAF7L gene. This alteration results from a G to C substitution at nucleotide position 1300, causing the valine (V) at amino acid position 434 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at